Background Image
Table of Contents Table of Contents
Previous Page  46 / 62 Next Page
Information
Show Menu
Previous Page 46 / 62 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 1, January/February 2020

44

AFRICA

hypertensive participants compared to the reference group

(non-hypertensive). About a quarter (26.9%) of hypertensive

patients had an increase in LA volume. Determinants of LA

volume were BMI, BSA, DBP, and LV septal thickness at

diastole in hypertension. Diastolic dysfunction was the only

independent predictor of LAR in hypertensive patients. Also,

we found no correlation between microalbuminuria and LA size

(volume) among hypertensive patients.

The LA length, surface area and volume were significantly

increased in patients with hypertension compared to the

controls. This finding was consistent with several reports that

showed that there is an increase in LA length and volume in

hypertension.

13,17,184,25

Contrary to the findings by Sun

et al.

in

China, changes in anterior–posterior and transverse diameters

were not significant.

12

There are possible explanations to these

differences, which include LA anatomical variations and severity

Table 3. Echocardiography parameters

Variable

Hypertensives (

n

=

52) Controls (

n

=

40)

p

-value

AOD (mm)

28.8 (26.6–31.0)

28.8 (26.5–31.4)

0.79

IVSD (mm)

9.2 (7.5–10.4)

8.4 (7.1–9.8)

0.28

IVSS (mm)

13.6 (12.7–15.3)

13.8 (12.1–15.0)

0.61

LVEDD (mm)

49.1 (45.0–54.0)

46.8 (43.1–51.0)

0.11

LVEDS (mm)

30.0 (25.9–34.7)

28.5 (25.5–32.6)

0.20

PWDD (mm)

9.4 (8.3–11.1)

8.6 (7.5–9.8)

0.89

PWDS (mm)

15.7 (13.8–17.3)

14.4 (12.7–15.9)

0.19

FS (%)

37.0 (34.2–42.0)

0.35 (0.31–0.40)

0.91

EF (%)

68.0 (61.2–74.0)

83.3 (66.7–76.0)

0.17

LVMI (g/m

2

)

86.0 (72.7–101.7)

73.3 (58.4–88.7)

0.01*

RWT

0.35 (0.32–0.44)

0.35 (0.31–0.35)

0.11

Peak E (cm/s)

75.3 (58.8–92.5)

80.0 (67.0–90.0)

0.43

Peak A (cm/s)

83.0 (62.2–96.0)

63.5 (51.0–83.7)

0.001*

E dec (ms)

199.0 (179.0–219.0)

189.0 (165.0–209.0)

0.23

IVRT (ms)

96.0 (83.5–105.0)

90.0 (78.0–101.0)

0.31

E/A ratio

0.89 (0.70–1.2)

1.24 (0.94–1.49)

<

0.0001*

S

lateral (m/s)

10.0 (7.0–12.0)

9.0 (8.0–12.0)

0.88

Lateral E

(m/s)

9.0 (7.0–11.0)

11.0 (9.0-15.0)

0.009*

Lateral A

(m/s)

11.0 (9.0–2.8)

9.0 (7.01–0.0)

0.002*

E/E

ratio

9.0 (6.9–10.7)

7.25 (5.7–8.8)

0.001*

Values are presented as median (interquartile range). *Statistically significant.

AOD, aortic root diameter; IVSD, interventricular septal diameter at diastole;

IVSS, interventricular septal diameter at systole; LVEDD, left ventricular end-

diastolic diameter; LVEDS, left ventricular end-systolic diameter; PWDD, poste-

rior wall diameter at diastole; PWDS, posterior wall diameter at systole; EF,

ejection fraction; FS, fractional shortening; LVMI, left ventricular mass index;

RWT, relative wall thickness; E, early mitral flow velocity; A, atrial contraction

velocity; dec, E wave deceleration time; IVRT, isovolumetric relaxation time; S

,

systolic myocardial velocity at lateral annulus; A

, myocardial velocity associated

with atrial contraction; E

, early diastolic myocardial velocity.

Table 4. Comparison of left atrial size between hypertensives and controls

Variable

Hypertensives

(

n

=

52)

Controls

(

n

=

40)

p

-value

LA anteroposterior diameter (mm) 38.1 (34.6–38.0) 36.7 (34.1–39.6) 0.064*

LA anteroposterior diameter

indexed BSA

19.8 (17.8–19.8) 19.1 (18.0–21.0) 0.148

LA transverse diameter (mm)

37.0 (32.7–49.8) 39.3 (34.6–42.8) 0.097*

LA longitudinal diameter (mm)

50.0 (45.0–55.0) 47.4 (44.0–51.8) 0.045

LA surface area (cm

2

)

17.9 (13.3–21.2) 15.5 (13.6–17.4) 0.003

LA volume, biplane (ml)

52.4 (38.9–65.7) 43.8 (35.2–48.5) 0.002

LA volume, biplane indexed BSA

(ml/m

2

)

28.1 (19.9–34.5) 22.9 (18.8–26.6) 0.003

*Statistically significant. LA, left atrial; BSA, body surface area.

Hypertension

Control

Number

40

30

20

10

0

p

<

0.0001

14

38

39

1

LAE

no LAE

Fig. 3.

Proportion of patients with LA enlargement in hyper-

tensive subjects and controls. LAE, left atrial enlarge-

ment.

Mild LAE

Moderate LAE Severe LAE

Grade

9

7

5

2

0

9

3

2

Fig. 4.

Classification of severity of LA enlargement according

to the American Society of Echocardiography. LAE,

left atrial enlargement.

Table 5. Pearson correlation for covariates of left atrial size (volume)

in hypertensive patients

Variable

Correlation coefficient,

r

p

-value (

n

=

52)

Age

0.008

0.544

BMI

0.402

0.004*

SBP

–0.040

0.782

DBP

–0.300

0.019*

IVSD

–0.022

0.880

LEVDD

0.360

0.009

PWDD

1.310

0.366

LVM/BSA

0.055

0.704

E/E

0.351

0.013*

E/A

0.368

0.009

RWT

0.073

0.621

Microalbuminuria (mg/g)

0.130

0.350

*Statistically significant. BMI, body mass index; SBD, systolic blood pressure;

DBP, diastolic blood pressure; IVSD, interventricular septal diameter at diastole;

LVMI, left ventricular mass index; LVEDD, left ventricular end-diastolic diam-

eter; PWDD, posterior wall diameter at diastole; RWT, relative wall thickness.